Naturally occurring and hard to patent, companies see $100M+ trials as a nonstarter
[25,28,41] Scientific evidence (efficacy): Research shows that CJC-1295 can increase GH and IGF-1 levels even in healthy individuals
Origins as a Mitochondrial-Derived Peptide MOTS-C peptide was first characterized in 2015 by Lee and colleagues, who showed that stressed muscle cells release this peptide, which then translocates to the nucleus to upregulate genes involved in adaptive stress resistance
Think of a peptide as a text message your cells send each other with a single instruction: "make more collagen here," "reduce inflammation there," "build new blood supply now." BPC-157's message is remarkably good at all three
Compounding pharmacies would gain the right to make these drugs
Research Highlights Stimulates Endogenous GH Release: Binds to pituitary GHS-R1a receptors and rapidly induces growth hormone secretion through calcium-mediated exocytosis 2